ABSTRACT
Due to the presence of protective mechanisms and blood-ocular barriers in the eye, drugs aimed at treating posterior segment ophthalmic disorder have to be administrated mostly through periocular or intravitreal injection. In the current study, we sought to investigate whether topical ophthalmic instillation of human mesenchymal stem cells (hMSCs)-derived exosomes can prevent and treat experimental autoimmune uveitis (EAU), a posterior segment ophthalmic disease induced in animals and considered a model of human autoimmune diseases of the eye. Our studies reveal that topical ophthalmic instillation of hMSCs-derived exosomes can effectively ameliorate EAU. More importantly, we demonstrate that exosomes modified by trans-activator of transcription peptide (TAT) were more effective than naive exosomes in penetrating ocular barrier and preventing/treating EAU. Taken together, these results indicate that topical ophthalmic instillation of TAT-peptide modified exosomes represents a novel non-invasive therapeutic strategy for posterior-segment ophthalmic disorders.
Subject(s)
Exosomes , Mesenchymal Stem Cells , Uveitis , Exosomes/metabolism , Exosomes/transplantation , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/cytology , Humans , Animals , Uveitis/therapy , Uveitis/metabolism , Uveitis/pathology , Administration, Ophthalmic , Mice , Autoimmune Diseases/therapy , Autoimmune Diseases/metabolism , Autoimmune Diseases/immunology , Mice, Inbred C57BL , Administration, Topical , Posterior Eye Segment/metabolism , FemaleABSTRACT
The relevance of regulatory T cells (Tregs) in induction of tolerance against corneal allografts has been well established. However, whether Tregs can be induced in the anterior chamber and suppress local alloimmune response after corneal transplantation is largely unknown. In the current study we report that not only can alloantigen specific Tregs be generated in the anterior chamber during corneal transplantation, they also play important roles in suppressing allograft rejection. Allograft rejected mice exhibit reduced Treg induction in the anterior chamber and the ability of aqueous humor and corneal endothelial cells from allograft rejected mice to induce Tregs is compromised. Further analysis revealed that the expression of immune-tolerance-related molecules is significantly decreased. Finally, we demonstrate that increasing Treg cells specifically in the anterior chamber can effectively suppress allograft rejection and exhibits better efficacy in promoting corneal allograft survival than systemic administration of Treg cells. Our current study may provide new ideas for the prevention and treatment of corneal transplant rejection.
Subject(s)
Corneal Transplantation , Endothelial Cells , Mice , Animals , Graft Survival , Anterior Chamber , T-Lymphocytes, Regulatory , Immune Tolerance , Graft Rejection/prevention & control , Mice, Inbred BALB C , Mice, Inbred C57BLABSTRACT
It has been reported that deletion of tumor necrosis factor-α-induced protein-8 like 2 (TNFAIP8L2, TIPE2) facilitates the activation of T-cell receptors. However, the role of TIPE2 in T-cell-mediated acute transplant rejection remains unclear. To illustrate the underlying cellular mechanisms, we transplanted BALB/c hearts into C57BL/6 wild-type (WT) or C57BL/6 mice deficient for TIPE2 (TIPE2-/-) and found that TIPE2-/- recipient mice showed significantly prolonged survival of heart allografts and suppressed maturation of CD11c+ dendritic cells (DCs), which largely abolished the activation and proliferation of alloreactive T cells and their cytotoxic activity. TIPE2-/- DCs increased CD4+CD25+Foxp3+CD127- regulatory T cells (Tregs)generation, likely by inhibiting DCs maturation and CD80 and CD86 expression. Administration of anti-CD25 abolished the allograft survival induced by TIPE2 deficiency. Moreover, TIPE2 deficiency increased IL-10 production in T cells and in recipient serum and allografts. Mechanistic studies revealed that TIPE2-/- restrained the maturation of DCs via inhibition of PI3K/AKT phosphorylation during alloantigen stimulation. Taken together, TIPE2 deficiency in recipient mice inhibited acute rejection by increasing Tregs generated by immature DCs. Thus, TIPE2 could be a therapeutic target for suppressing rejection in organ transplantation.
Subject(s)
Heart Transplantation , T-Lymphocytes, Regulatory , Mice , Animals , Phosphatidylinositol 3-Kinases/metabolism , Dendritic Cells , Mice, Inbred C57BL , Allografts , Mice, Inbred BALB C , Graft Survival , Graft Rejection , Intracellular Signaling Peptides and Proteins/geneticsABSTRACT
The tumor suppressor PDCD4 is a proinflammatory protein that promotes activation of the transcription factor NF-kappaB and suppresses interleukin 10 (IL-10). Here we found that mice deficient in PDCD4 were protected from lipopolysaccharide (LPS)-induced death. The induction of NF-kappaB and IL-6 by LPS required PDCD4, whereas LPS enhanced IL-10 induction in cells lacking PDCD4. Treatment of human peripheral blood mononuclear cells with LPS resulted in lower PDCD4 expression, which was due to induction of the microRNA miR-21 via the adaptor MyD88 and NF-kappaB. Transfection of cells with a miR-21 precursor blocked NF-kappaB activity and promoted IL-10 production in response to LPS, whereas transfection with antisense oligonucleotides to miR-21 or targeted protection of the miR-21 site in Pdcd4 mRNA had the opposite effect. Thus, miR-21 regulates PDCD4 expression after LPS stimulation.
Subject(s)
Apoptosis Regulatory Proteins/immunology , Gene Expression Regulation/immunology , MicroRNAs/immunology , RNA-Binding Proteins/immunology , Signal Transduction/immunology , Toll-Like Receptor 4/immunology , Animals , Apoptosis Regulatory Proteins/metabolism , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Humans , Immunoprecipitation , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Lipopolysaccharides/immunology , Lipopolysaccharides/pharmacology , Membrane Glycoproteins/immunology , Membrane Glycoproteins/metabolism , Mice , MicroRNAs/metabolism , NF-kappa B/immunology , NF-kappa B/metabolism , Polymerase Chain Reaction , RNA-Binding Proteins/metabolism , Receptors, Interleukin-1/immunology , Receptors, Interleukin-1/metabolism , Toll-Like Receptor 4/metabolism , TransfectionABSTRACT
Autoimmune diseases are a physiological state that immune responses are directed against and damage the body's own tissues. Numerous studies have demonstrated promising therapeutic effects in certain autoimmune diseases by targeting IL-23/IL-17 axis, mostly through using Abs against IL-23 or IL-17A. Pyrrole-imidazole polyamides are nuclease-resistant compounds that inhibit gene expression through binding to the minor groove of DNA. To develop a novel gene-silencing agent that targets IL-23/IL-17 axis, we designed polyamide that specifically binds to the transcription factor c-Rel-binding site located in the promoter of IL-23p19 subunit. Our study showed that this polyamide is capable of entering into nucleus with high efficiency in dendritic cells and macrophage. In addition, it prevented the binding of c-Rel to the promoter of IL-23p19 in vivo and specifically inhibited the expression of IL-23. More importantly, we demonstrated that this polyamide is therapeutically effective using both the imiquimod-induced psoriasis and experimental autoimmune uveitis mouse models. Taken together, these results indicate that pyrrole-imidazole polyamide targeting IL-23p19 could be a novel and feasible therapeutic strategy for patients with autoimmune diseases.
Subject(s)
Autoimmune Diseases/drug therapy , Autoimmune Diseases/genetics , Gene Silencing , Interleukin-23 Subunit p19/antagonists & inhibitors , Nylons/pharmacology , Animals , Autoimmune Diseases/chemically induced , Autoimmune Diseases/immunology , Female , Imidazoles/pharmacology , Imiquimod , Interleukin-23 Subunit p19/genetics , Interleukin-23 Subunit p19/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Molecular Structure , Psoriasis/chemically induced , Psoriasis/drug therapy , Psoriasis/genetics , Psoriasis/immunology , Pyrroles/pharmacology , Uveitis/chemically induced , Uveitis/drug therapy , Uveitis/genetics , Uveitis/immunologyABSTRACT
The relevance of Tregs in the induction of tolerance against corneal allografts has been well established. Although it is well known that the conversion of Tregs into effector-like cells contributes to the loss of corneal immune privilege, the underlying mechanism is still not fully understood. Using heterologous penetrating keratoplasty model, we found that Tregs from corneal allograft rejected mice (inflam-Tregs) exhibit impaired function and characteristics of effector T cells. Further study showed that the expression of NF-κB c-Rel, a key mediator of effector T cell function, was significantly increased in inflam-Tregs. Mechanistic study revealed that elevated NF-κB c-Rel level in inflam-Tregs impaired Treg function through the promotion of inflammatory cytokine production and glycolysis. More importantly, we demonstrated that targeting NF-κB c-Rel was able to improve the immune suppressive function of inflam-Tregs in vitro and enhance the potential of them to suppress corneal transplantation rejection. Therefore, our current study identified NF-κB c-Rel as a key mediator of the conversion of Tregs into effector-like cells when under inflammatory environment.
Subject(s)
Corneal Transplantation , T-Lymphocytes, Regulatory , Allografts , Animals , Cornea , Graft Rejection/etiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , NF-kappa B , Transplantation, HomologousABSTRACT
Th17 cell is a well-known lineage of CD4+ effector Th cells that selectively produce IL-17A and play critical roles during the pathogenesis of autoimmune disease. A microRNA (miRNA) is a small noncoding RNA molecule that functions in posttranscriptional regulation of gene expression. Recently, an increasing number of studies have demonstrated that multiple miRNAs are dysregulated in patients with various autoimmune diseases and mediate autoimmune disease pathologic condition at least in part through the regulation of Th17 response. However, among the few miRNAs identified so far that play possible roles in the differentiation of Th17 cells, they all regulate the Th17 response through targeting negative or positive regulators of Th17 differentiation. In the current study, we sought to identify new miRNAs that can directly regulate the expression of IL-17A, the most important cytokine produced by Th17 cells. Our results showed that the 3' untranslated region of mouse IL-17A can act as a negative regulatory element to downregulate gene expression. Further study revealed that miR-340 can specifically bind to the 3' untranslated region of mouse IL-17A and downregulate the expression of endogenous IL-17A. More importantly, we demonstrated that treatment with miR-340 alleviates the clinical severity of imiquimod-induced psoriasis in mice through the downregulation of IL-17A. These data indicate that miR-340 may be a useful therapeutic target for the treatment of psoriasis and other IL-17A-mediated autoimmune diseases.
Subject(s)
Down-Regulation/immunology , Interleukin-17/immunology , MicroRNAs/immunology , Psoriasis/immunology , 3' Untranslated Regions/immunology , Animals , Down-Regulation/drug effects , Female , Humans , Imiquimod/adverse effects , Imiquimod/pharmacology , Mice , Mice, Inbred BALB C , Psoriasis/chemically induced , Psoriasis/pathologyABSTRACT
Dendritic cells (DCs) are professional antigen-presenting cells. The main function of DCs is to process antigen and present it to the T cells to induce T cell immunity. In addition to their function as potent stimulators of adaptive immunity, DCs are also crucial for maintaining immunological tolerance through the induction of peripheral regulatory T cells. Tumor necrosis factor-α-induced protein 8-2 (Tumor necrosis factor-α induced protein-8-like 2, TNFAIP8L2 or TIPE2) was expressed primarily by immune cells and maintains immune tolerance through the negative regulation of innate and adaptive immune responses. Previous studies indicate that TIPE2 in DCs may inhibit the innate immune response to RNA. However, the role of TIPE2 in DCs in the induction of peripheral tolerance remains unknown. Our current study showed that Tipe2-deficient DCs are more immature under homeostatic condition and consequently promote the induction of peripheral Tregs in the gut mucosa. Mechanistic studies revealed that TIPE2 promotes the expression of DC maturation markers CD80 and CD86 through the activation of PI3K-PKCδ-MAPK signaling pathway during the differentiation of DCs. Taken together, these results indicate that, in addition to acting as a negative regulator of pathogen-induced immune response, TIPE2 in DCs is also capable of promoting immune response under homeostatic condition through the suppression of peripheral tolerance.
Subject(s)
Dendritic Cells/immunology , Intestinal Mucosa/immunology , Intracellular Signaling Peptides and Proteins/pharmacology , T-Lymphocytes, Regulatory/immunology , Transcriptional Activation/immunology , Animals , Cell Differentiation/drug effects , Cells, Cultured , Homeostasis , Humans , Immune Tolerance/drug effects , Immunity, Innate/drug effects , Protein Kinases/drug effects , Protein Kinases/metabolism , Signal Transduction , Transcriptional Activation/drug effectsABSTRACT
T helper type 17 (Th17) cells and regulatory T (Treg) cells are two distinct T-cell subsets with opposite effects on immune functions. While Th17 cells are a key effector in the immune response and play critical roles in the development of autoimmunity and inflammation, Treg cells orchestrate the overall immune response and maintain peripheral immune tolerance by regulating the activity of the effector T cells. However, the developmental pathways for Th17 and Treg cells are reciprocally interconnected and there is a significant amount of plasticity between them. Disturbed Th17/Treg balance contributes to the development of autoimmune diseases, like experimental autoimmune encephalomyelitis and multiple sclerosis. MicroRNAs (miRNAs) are small non-coding RNA molecules that post-transcriptionally regulate gene expression. Recently, emerging evidence demonstrates that miRNAs play an important role in regulating the pathogenesis of autoimmune diseases through the modulation of Th17/Treg balance. This review will provide an overview of the dysregulated miRNAs and their functions in modulating the Th17/Treg balance in autoimmune diseases.
Subject(s)
Autoimmune Diseases/immunology , MicroRNAs/metabolism , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Animals , Autoimmune Diseases/pathology , Autoimmunity/immunology , Humans , Lymphocyte Count , MiceABSTRACT
Regulatory T cells (Tregs) can be divided into thymus-derived Treg (tTregs) and peripheral induced Tregs (pTregs) in vivo according to their origins and are essential for the maintenance of immune hemostasis and immune tolerance. Tumor necrosis factor-α-induced protein 8 like 2 (TIPE2) is expressed primarily by immune cells and is a negative regulator of the innate and adaptive immune response. Previous studies indicate that TIPE2 is required for the expression of Treg signature genes and promotes leading-edge formation in neutrophils through cytoskeleton remodeling. In the current study, we showed that TIPE2 deficient mice accumulate more Treg cells in the thymus. Further studies revealed that TIPE2 deficiency doesn't affect the development and apoptosis of tTregs. Instead, TIPE2 promotes the chemotaxis of tTregs in vitro, which may account for the accumulation of Tregs in the thymus of TIPE2 deficient mice. Mechanistic study revealed that TIPE2 promotes the polarization of pAKT and F-actin in tTregs undergoing directed migration. Taken together, these results demonstrated that TIPE2 enhances the cytoskeleton remodeling and promotes the thymus egress of tTregs, which may play an important role in the maintenance of self-tolerance.
Subject(s)
Intracellular Signaling Peptides and Proteins/metabolism , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/metabolism , Thymus Gland/cytology , Animals , Cell Polarity , Chemotaxis , Intracellular Signaling Peptides and Proteins/deficiency , Mice, Inbred C57BLABSTRACT
Regulatory T (Treg) cells are essential for maintaining immune homeostasis. Although Foxp3 expression marks the commitment of progenitors to Treg cell lineage, how Treg cells are generated during lymphocyte development remains enigmatic. We report here that the c-Rel transcription factor controlled development of Treg cells by promoting the formation of a Foxp3-specific enhanceosome. This enhanceosome contained c-Rel, p65, NFAT, Smad, and CREB. Although Smad and CREB first bound to Foxp3 enhancers, they later moved to the promoter to form the c-Rel enhanceosome. c-Rel-deficient mice had up to 90% reductions of Treg cells compared to wild-type mice, and c-Rel-deficient T cells were compromised in Treg cell differentiation. Thus, Treg cell development is controlled by a c-Rel enhanceosome, and strategies targeting Rel-NF-kappaB can be effective for manipulating Treg cell function.
Subject(s)
Forkhead Transcription Factors/genetics , Gene Expression Regulation , Proto-Oncogene Proteins c-rel/genetics , T-Lymphocytes, Regulatory/immunology , Transcription Factor RelA/immunology , Animals , Cell Differentiation , Cyclic AMP Response Element-Binding Protein/metabolism , Mice , Mice, Inbred C57BL , NFATC Transcription Factors/metabolism , Promoter Regions, Genetic , Proto-Oncogene Proteins c-rel/metabolism , Smad Proteins/metabolism , Transcription Factor RelA/metabolismABSTRACT
Autoimmune Th1 and Th17 responses are critical for the development of central nervous system (CNS) pathology in experimental autoimmune encephalomyelitis (EAE), an animal model for human multiple sclerosis. Although macrophages play important roles in the development of Th1 and Th17 responses, whether modulating macrophage gene transcription can diminish the Th1- and Th17 cell-induced CNS pathology is unclear. In this study, we successfully silenced the expression of the transcription factor c-Rel in macrophages of mice with EAE (including those infiltrating the CNS) using chemically modified c-Rel-specific siRNAs delivered by nanoparticles. Knocking down c-Rel in macrophages in vitro inhibited expression of NF-κB targets, such as pro-inflammatory cytokines interleukin 1ß (IL-1ß) and p40 of interleukin 12 (IL-12)/interleukin 23 (IL-23), in macrophages, leading to reduced interferon γ (IFN-γ) and interleukin 17A (IL-17A) production by co-cultured MOG-specific T cells from EAE mice. Such effects correlated with diminished T-cell infiltration in the CNS, reduced clinical symptoms, as well as downregulated pathogenic Th1 and Th17 responses in EAE mice. Taken together, our findings indicate that targeting c-Rel in macrophages dampens CNS-specific Th1 and Th17 immune responses, and can be effective for treating autoimmune diseases of the CNS.
Subject(s)
Encephalomyelitis, Autoimmune, Experimental/immunology , Gene Silencing , Macrophages/metabolism , Proto-Oncogene Proteins c-rel/metabolism , Th1 Cells/immunology , Th17 Cells/immunology , Animals , Central Nervous System/pathology , Cytokines/metabolism , Down-Regulation , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Gene Knockdown Techniques , Inflammation Mediators/metabolism , Interferon-gamma/metabolism , Interleukin-17/metabolism , Mice , Mice, Inbred C57BL , Myelin-Oligodendrocyte Glycoprotein/immunology , NF-kappa B/metabolism , Nanoparticles/chemistry , RAW 264.7 Cells , RNA, Small Interfering/metabolism , Up-RegulationABSTRACT
The TNF-α-induced protein 8 (TNFAIP8 or TIPE) is a risk factor for cancer and bacterial infection, and its expression is upregulated in a number of human cancers. However, its physiologic and pathologic functions are unclear. In this study, we describe the generation of TIPE-deficient mice and their increased sensitivity to colonic inflammation. TIPE-deficient mice were generated by germ line gene targeting and were born without noticeable developmental abnormalities. Their major organs, including lymphoid organs and intestines, were macroscopically and microscopically normal. However, after drinking dextran sodium sulfate-containing water, TIPE-deficient mice developed more severe colitis than wild type mice did, as demonstrated by decreased survival rates, increased body weight loss, and enhanced leukocyte infiltration, bacterial invasion, and inflammatory cytokine production in the colon. Bone marrow chimeric experiments revealed that TIPE deficiency in nonhematopoietic cells was responsible for the exacerbated colitis in TIPE-deficient mice. Consistent with this result, TIPE-deficient intestinal epithelial cells had increased rate of cell death and decreased rate of proliferation as compared with wild type controls. These findings indicate that TIPE plays an important role in maintaining colon homeostasis and in protecting against colitis.
Subject(s)
Apoptosis Regulatory Proteins/deficiency , Colitis/genetics , Colitis/pathology , Animals , Apoptosis Regulatory Proteins/genetics , Cell Line , Cell Proliferation , Cell Survival/genetics , Colitis/chemically induced , Colitis/metabolism , Cytokines/blood , Cytokines/metabolism , Dextran Sulfate/adverse effects , Disease Models, Animal , Disease Progression , Epithelial Cells/metabolism , Female , Gene Order , Gene Targeting , Genetic Vectors/genetics , Humans , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Leukocytes/pathology , Male , Mice , Mice, Knockout , PhenotypeABSTRACT
Psoriasis is a chronic inflammatory disorder of the skin. Accumulating evidence indicates that the Rel gene, a member of the NF-κB family, is a risk factor for the disease. We sought to investigate whether psoriasis can be prevented by directly targeting the Rel gene transcript, i.e., the c-Rel mRNA. Using chemically-modified c-Rel specific siRNA (siRel) and poly(ethylene glycol)-b-poly(l-lysine)-b-poly(l-leucine) (PEG-PLL-PLLeu) micelles, we successfully knocked down the expression of c-Rel, and showed that the expression of cytokine IL-23, a direct target of c-Rel that can drive the development of IL-17-producing T cells, was markedly inhibited. More importantly, treating mice with siRel not only prevented but also ameliorated imiquimod (IMQ)-induced psoriasis. Mechanistic studies showed that siRel treatment down-regulated the expression of multiple inflammatory cytokines. Taken together, these results indicate that the susceptibility gene Rel can be targeted to treat and prevent psoriasis.
Subject(s)
Drug Delivery Systems , Genes, rel/genetics , Genetic Predisposition to Disease , Psoriasis/drug therapy , Psoriasis/genetics , RNA, Small Interfering/therapeutic use , Animals , Humans , Mice , Mice, Inbred BALB C , RNA-Induced Silencing Complex/therapeutic use , Real-Time Polymerase Chain ReactionABSTRACT
Regulatory T (Treg) cells play an integral role in maintaining immune homeostasis and preventing autoimmune diseases. Forkhead box P3 expression marks the commitment of progenitor cells to the Treg lineage. Although the essential function of the nuclear factor (NF)-κB family transcription factor c-Rel in the regulation of natural Treg cells has been firmly established, little is known about whether c-Rel is involved in the in vivo generation of peripheral Treg cells (pTregs), which develop from mature CD4+ conventional T cells outside of the thymus. We sought to answer this question through the induction of pTregs in the eye and gut mucosa using ovalbumin-specific T cell receptor transgenic mice that do or do not express c-Rel. Our results showed that Tregs can be induced in the eye in a c-Rel-dependent manner when immune-mediated inflammation occurs. However, c-Rel is dispensable for the induction of pTregs in the gut mucosa after oral antigen administration. Thus, c-Rel may play distinct roles in regulating the development of pTregs in different organs. Abbreviations ACAID: Anterior Chamber-Associated Immune Deviation; ATF: activating transcription factor; CREB: cAMP responsive element-binding protein; DMEM: Dulbecco minimum essential medium; HBSS: Hanks Balanced Salt Solution; NFAT: Nuclear Factor of Activated T cells; PBS: Phosphate-buffered saline; PE: Phycoerythrin; WT: wild type.
Subject(s)
Cell Lineage/immunology , Eye/immunology , Intestinal Mucosa/immunology , Proto-Oncogene Proteins c-rel/immunology , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes, Regulatory/immunology , Activating Transcription Factor 1 , Adoptive Transfer , Animals , Cell Differentiation , Cyclic AMP Response Element-Binding Protein/genetics , Cyclic AMP Response Element-Binding Protein/immunology , Eye/cytology , Eye/drug effects , Female , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/immunology , Gene Expression Regulation , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Lymph Nodes/cytology , Lymph Nodes/drug effects , Lymph Nodes/immunology , Lymphocyte Count , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , NFATC Transcription Factors/genetics , NFATC Transcription Factors/immunology , Organ Specificity , Ovalbumin/administration & dosage , Proto-Oncogene Proteins c-rel/deficiency , Proto-Oncogene Proteins c-rel/genetics , Receptors, Antigen, T-Cell/genetics , Signal Transduction , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/transplantationABSTRACT
MicroRNA-21 (miR-21) is an oncomiR and significantly upregulated in a wide range of cancers. It is strongly involved in apoptosis and oncogenesis, since most of its reported targets are tumor suppressors. Recently, miR-21 was found to be correlated with the pathogenesis of autoimmune diseases and may play an essential role in regulating autoimmune responses. In particular, miR-21 promotes Th17 cell differentiation, which mediates the development of multiple autoimmune diseases. In this article, we review the current research on the mechanisms that regulate miR-21 expression, the potential of miR-21 as a diagnostic biomarker for autoimmune disease and the mechanisms by which miR-21 promotes the development of autoimmune disease. We also discussed the therapeutic potential of targeting miR-21 in treating patients with autoimmune disease.
Subject(s)
Autoimmune Diseases/genetics , MicroRNAs/genetics , Animals , Apoptosis/genetics , Apoptosis/immunology , Autoimmune Diseases/diagnosis , Autoimmune Diseases/immunology , Autoimmune Diseases/therapy , Autoimmunity/genetics , Cell Differentiation/genetics , Cell Differentiation/immunology , DNA Methylation , Gene Expression Regulation , Humans , RNA Interference , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Th17 Cells/immunology , Th17 Cells/metabolismABSTRACT
Phagocytosis and oxidative burst are two major effector arms of innate immunity. Although it is known that both are activated by Toll-like receptors (TLRs) and Rac GTPases, how their strengths are controlled in quiescent and TLR-activated cells is not clear. We report here that TIPE2 (TNFAIP8L2) serves as a negative regulator of innate immunity by linking TLRs to Rac. TLRs control the expression levels of TIPE2, which in turn dictates the strengths of phagocytosis and oxidative burst by binding to and blocking Rac GTPases. Consequently, TIPE2 knockout cells have enhanced phagocytic and bactericidal activities and TIPE2 knockout mice are resistant to bacterial infection. Thus, TIPE2 sets the strengths of phagocytosis and oxidative burst and may be targeted to effectively control infections.
Subject(s)
Intracellular Signaling Peptides and Proteins/physiology , Phagocytosis , Respiratory Burst/immunology , Amino Acid Motifs , Animals , Cell Line , Cell Membrane/metabolism , Crosses, Genetic , Humans , Hydrolysis , Intracellular Signaling Peptides and Proteins/metabolism , Macrophages/cytology , Macrophages/microbiology , Mice , Mice, Inbred C57BL , Protein Transport , Toll-Like Receptors/metabolism , rac GTP-Binding Proteins/metabolismABSTRACT
Sustained Toll-like receptor (TLR) stimulation continuously activates antimicrobial genes but paradoxically represses inflammatory genes. This phenomenon, termed TLR tolerance, is essential for preventing fatal inflammatory conditions such as sepsis, but its underlying mechanisms are unclear. We report here that NF-κB binding nucleic acids of gene promoters are tolerogenic motifs, which selectively recruit an NcoR-Hdac3-deacetylated-p50 repressosome to inflammatory genes. Genome-wide analyses of TLR4-induced genes revealed that NF-κB motifs were the only regulatory elements significantly enriched in tolerizable genes. Mutating the NF-κB motifs of tolerizable genes converted them into nontolerizable ones, whereas inserting NF-κB binding motifs into nontolerizable genes conferred the tolerance. Although NF-κB p50 was essential for assembling the repressosome, genetic disruption of the NcoR-Hdac3 interaction alone was sufficient to completely abolish TLR4 tolerance and to render mice vulnerable to sepsis. Thus, the specificity of TLR tolerance is dictated by evolutionally conserved nucleic acid motifs that bound by NF-κB and the NcoR repressosome.
Subject(s)
Immune Tolerance/immunology , NF-kappa B p50 Subunit/immunology , Nuclear Receptor Co-Repressor 1/immunology , Toll-Like Receptor 4/immunology , Acetylation , Amino Acid Motifs/immunology , Animals , Bone Marrow Cells/cytology , Cell Line , Gene Expression/immunology , Histone Deacetylases/immunology , Histone Deacetylases/metabolism , Immune Tolerance/genetics , Lipopolysaccharides/immunology , Lipopolysaccharides/pharmacology , Macrophages/cytology , Mice , Mice, Inbred C57BL , NF-kappa B p50 Subunit/metabolism , Nuclear Receptor Co-Repressor 1/genetics , Nuclear Receptor Co-Repressor 1/metabolism , Shock, Septic/immunology , Shock, Septic/prevention & control , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolismABSTRACT
Death of pancreatic ß cells is a pathological hallmark of type 1 diabetes (T1D). However, the molecular mechanisms of ß cell death and its regulation are poorly understood. Here we describe a unique regulatory pathway of ß cell death that comprises microRNA-21, its target tumor suppressor PDCD4, and its upstream transcriptional activator nuclear factor-κB (NF-κB). In pancreatic ß cells, c-Rel and p65 of the NF-κB family activated the mir21 gene promoter and increased miR-21 RNA levels; miR-21 in turn decreased the level of PDCD4, which is able to induce cell death through the Bax family of apoptotic proteins. Consequently, PDCD4 deficiency in pancreatic ß cells renders them resistant to death, and PDCD4 deficiency in NOD or C57BL/6 mice conferred resistance to spontaneous diabetes and diabetes induced by autoimmune T cells or the ß cell toxin streptozotocin (STZ). Thus, the NF-κB-microRNA-21-PDCD4 axis plays a crucial role in T1D and represents a unique therapeutic target for treating the disease.
Subject(s)
Apoptosis Regulatory Proteins/metabolism , Cell Death/physiology , Diabetes Mellitus, Type 1/immunology , Gene Expression Regulation/immunology , Insulin-Secreting Cells/physiology , MicroRNAs/metabolism , NF-kappa B/metabolism , RNA-Binding Proteins/metabolism , Analysis of Variance , Animals , Apoptosis Regulatory Proteins/deficiency , Apoptosis Regulatory Proteins/immunology , Cell Death/genetics , DNA Primers/genetics , Diabetes Mellitus, Type 1/prevention & control , Flow Cytometry , Immunoblotting , Insulin-Secreting Cells/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , MicroRNAs/immunology , NF-kappa B/immunology , RNA-Binding Proteins/immunology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
The integrity of the corneal epithelium is essential for the maintenance of the physiological function of the cornea. Studies have found that inflammation greatly delays corneal wound healing. NF-κB c-Rel is preferentially expressed by immune cells and promotes the expression of inflammatory cytokines. In the current study, we sought to investigate whether c-Rel could be used as a potential therapeutic target for treating a corneal injury. Our studies reveal that expressions of c-Rel and its inflammatory targets are significantly increased in the cornea of mice with corneal injury. In addition, we find that c-Rel-deficient mice exhibit accelerated corneal wound healing and reduced expression of inflammatory cytokines. Further studies show that topical treatment on the corneal surface using nano-polymers or exosomes loaded with c-Rel-specific siRNA (siRel) can effectively accelerate regular and diabetic corneal wound healing. More importantly, we find that exosomes, as carriers of siRel, showed better efficacy than nano-polymers in treating corneal injury. We further demonstrate that exosomes secreted by mesenchymal stem cells can efficiently transfer siRNA into macrophages and dendritic cells but not T cells. Taken together, these results indicate that blocking c-Rel may represent an attracting strategy for the treatment of both regular and diabetic corneal injury.